Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MAP3K9 mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the messenger RNA encoding Mitogen-activated protein kinase kinase kinase 9 (MAP3K9), also known as Mixed Lineage Kinase 1 (MLK1). This region contains multiple binding sites for microRNAs (miRNAs), such as miR-7, miR-148a, miR-34a, and miR-125b, which post-transcriptionally regulate MAP3K9 expression by inducing mRNA degradation or inhibiting translation (nih.gov, researchgate.net). MAP3K9 is a serine/threonine kinase that activates the JNK and p38 MAPK pathways, playing a pivotal role in cell proliferation, apoptosis, and stress responses (nih.gov). Dysregulation of the MAP3K9 mRNA 3′UTR, often through the downregulation of its targeting miRNAs or mutations in binding sites, leads to MAP3K9 overexpression, which is associated with the progression of various cancers, including lung, pancreatic, and gastric carcinomas, as well as inflammatory diseases like osteoarthritis (nih.gov, aging-us.com). Consequently, the MAP3K9 mRNA 3′UTR is considered a potential therapeutic target for RNA-based interventions, such as miRNA mimics or antisense oligonucleotides, aimed at restoring normal MAP3K9 levels to inhibit tumor growth and metastasis (europeanreview.org, nih.gov).
miRNA-mediated translational repression and mRNA degradation
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 9 mRNA 3′ untranslated region (MAP3K9 mRNA 3′UTR).